Responses
Regular and Young Investigator Award Abstracts
Other
1406 A novel PTK7-directed antibody-drug conjugate (ADC) PRO1107 demonstrated broad antitumor activity with a promising safety profile in preclinical models
Compose a Response to This Article
Other responses
No responses have been published for this article.
